Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Intrathecal baclofen: does tolerance occur?

Abstract

Concern over the development of tolerance in patients on continuous intrathecal baclofen therapy has arisen as this new form of treatment for spasticity has gained wider use. We have studied time-dose relationships in 18 spinal cord injured patients who have undergone intrathecal baclofen infusion pump implantation since February 1988 in our facility. Our data show that there was a significant increase in baclofen dosage needed to control spasticity during the first 12 months post implantation. After 12 months, however, no significant change in dosage requirement was detected. In addition, there was no significant difference between completely and incompletely spinal cord injured patients with regard to both the initial dose and the tolerance trend.

References

  1. Penn R D, Kroin J S (1987) Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 66(2): 181–5.

    CAS  Article  Google Scholar 

  2. Muller H, Zierski J, Dralle D, Borner U, Hoffmann O (1987) The effect of intrathecal baclofen on electrical muscle activity in spasticity. J Neurol 234(5): 348–52.

    CAS  Article  Google Scholar 

  3. Zierski J, Muller H, Dralle D, Wurdinger T (1988) Implanted pump systems for treatment of spasticity. Acta Neurochir Suppl (Wien) 43: 94–9.

    CAS  Google Scholar 

  4. Parke B, Penn R D, Savoy S M, Carcos D (1989) Functional outcome after delivery of intrathecal baclofen. Arch Phys Med Rehabil 70(1): 30–2.

    CAS  PubMed  Google Scholar 

  5. Penn R D, Savoy S M, Corcos D, Latash M, Gottlieb G, Parke B et al (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320(23): 1517–21.

    CAS  Article  Google Scholar 

  6. Ochs G, Struppler A, Meyerson B A, Linderoth B, Gybels J, Gardner B P, Teddy P et al (1989) Intrathecal baclofen for long-term treatment of spasticity: a multi-center study. J Neurol Neurosurg Psychiatry 52: 933–9.

    CAS  Article  Google Scholar 

  7. Broseta J, Garcia-March G, Sanchez-Ledesma M J, Anaya J, Silva I (1990) Chronic intrathecal baclofen administration in severe spasticity. Stereotact Funct Neurosurg 54–55: 147–53.

    Article  Google Scholar 

  8. Lazorthes Y, Sallerin-Caute B, Verdie J C, Bastide R, Carillo J P (1990) Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 72: 393–402.

    CAS  Article  Google Scholar 

  9. Loubser P G, Narayan R K, Sandin K J, Donovan W H, Russel K D (1991) Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 29(1): 48–64.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Sahuquillo J, Muxi T, Noguer M, Jodar R, Closa C, Rubio E et al (1991) Intraspinal baclofen in the treatment of severe spasticity and spasms. Acta Neurochir (Wien) 110: 166–173.

    CAS  Article  Google Scholar 

  11. Meythaler J M, Steers W D, Tuel S M, Cross L L, Haworth C S (1992) Continuous intrathecal baclofen in spinal cord spasticity. Am J Phys Med Rehabil 71: 321–7.

    CAS  Article  Google Scholar 

  12. Stevens C W, Yaksh T L (1989) Potency of infused spinal anti-nociceptive agents is inversely related to magnitude of tolerance after continuous infusion. J Pharmacol Exp Ther 250(1): 321–7.

    Google Scholar 

  13. Price G W, Wilkin G P, Turnbull M J, Bowery N G (1984) Are baclofen-sensitive GABA-B receptors present on primary afferent terminals of the spinal cord? Nature 307: 71–4.

    CAS  Article  Google Scholar 

  14. Golstein A, Aronow L, Kalman S M, editors (1974) Principles of Drug Action. John Wiley & Sons, New York: 459–68.

    Google Scholar 

  15. Penn R D, Kroin J S (1984) Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1: 1078.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Additional information

This study will be presented as a poster in IRMA-VII Washington DC, April 9–16, 1994.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Akman, M., Loubser, P., Donovan, W. et al. Intrathecal baclofen: does tolerance occur?. Spinal Cord 31, 516–520 (1993). https://doi.org/10.1038/sc.1993.84

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/sc.1993.84

Keywords

  • intrathecal baclofen
  • spasticity
  • spinal cord injury
  • tolerance

Further reading

Search

Quick links